247 related articles for article (PubMed ID: 17662696)
1. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells.
Jin W; Scotto KW; Hait WN; Yang JM
Biochem Pharmacol; 2007 Sep; 74(6):851-9. PubMed ID: 17662696
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs.
Baker EK; Johnstone RW; Zalcberg JR; El-Osta A
Oncogene; 2005 Dec; 24(54):8061-75. PubMed ID: 16091741
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells.
Wu H; Hait WN; Yang JM
Cancer Res; 2003 Apr; 63(7):1515-9. PubMed ID: 12670898
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
[TBL] [Abstract][Full Text] [Related]
5. Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells.
Kusaba H; Nakayama M; Harada T; Nomoto M; Kohno K; Kuwano M; Wada M
Eur J Biochem; 1999 Jun; 262(3):924-32. PubMed ID: 10411657
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.
Mutoh K; Tsukahara S; Mitsuhashi J; Katayama K; Sugimoto Y
Cancer Sci; 2006 Nov; 97(11):1198-204. PubMed ID: 16925584
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of RNA helicase A by DNA-dependent protein kinase is indispensable for expression of the MDR1 gene product P-glycoprotein in multidrug-resistant human leukemia cells.
Zhong X; Safa AR
Biochemistry; 2007 May; 46(19):5766-75. PubMed ID: 17441731
[TBL] [Abstract][Full Text] [Related]
8. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
[TBL] [Abstract][Full Text] [Related]
9. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.
Han CY; Cho KB; Choi HS; Han HK; Kang KW
Carcinogenesis; 2008 Sep; 29(9):1837-44. PubMed ID: 18390843
[TBL] [Abstract][Full Text] [Related]
10. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW
Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528
[TBL] [Abstract][Full Text] [Related]
11. Involvement of MyoD and PEA3 in regulation of transcription activity of MDR1 gene.
Zhao Y; Liu J; Hong Q; Yang C; Chen L; Chen Y; Wang Q; Zhao K; Jin W
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):900-7. PubMed ID: 20980337
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.
Comerford KM; Wallace TJ; Karhausen J; Louis NA; Montalto MC; Colgan SP
Cancer Res; 2002 Jun; 62(12):3387-94. PubMed ID: 12067980
[TBL] [Abstract][Full Text] [Related]
13. New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein.
Labialle S; Dayan G; Gayet L; Rigal D; Gambrelle J; Baggetto LG
Nucleic Acids Res; 2004; 32(13):3864-76. PubMed ID: 15272088
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
Ogretmen B; Safa AR
Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
[TBL] [Abstract][Full Text] [Related]
15. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
Stege A; Priebsch A; Nieth C; Lage H
Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
[TBL] [Abstract][Full Text] [Related]
17. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs.
Jin W; Liu Y; Xu SG; Yin WJ; Li JJ; Yang JM; Shao ZM
Breast Cancer Res Treat; 2010 Nov; 124(1):39-48. PubMed ID: 20037778
[TBL] [Abstract][Full Text] [Related]
18. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
Kantharidis P; El-Osta A; deSilva M; Wall DM; Hu XF; Slater A; Nadalin G; Parkin JD; Zalcberg JR
Clin Cancer Res; 1997 Nov; 3(11):2025-32. PubMed ID: 9815593
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
[TBL] [Abstract][Full Text] [Related]
20. Strategies for inhibition of MDR1 gene expression.
Xu D; Kang H; Fisher M; Juliano RL
Mol Pharmacol; 2004 Aug; 66(2):268-75. PubMed ID: 15266017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]